The future of
single-domain antibodies



News-Events

Join our webinar on October 18

Paris, France - 18 October

Dr. Jean-Christophe Rain, Director of Technology Development & Dr. Imenne Boubakour, Business Development Manager, will give a 30 minutes long webinar entitled:

"In vitro selection & validation of synthetic single-domain antibodies & applications"

Join us on October 18th at 4:00 pm (Paris time).

Why should you attend?

> Discover why Hybribody VHHs are so reliable and innovative.

> Learn more about our unique phage display antibody selection process.

> Find out how Hybribody is a versatile tool that can be used in many ways: ELISA, PLA, IF...

> Ask your questions to our experts directly in the chat.

REGISTER

 

Add to Calendar 18-10-2018 16:00:00 18-10-2018 16:30:00 40 Join us for our Hybribody webinar We will give a presentation on October 18th at 4:00 pm (Paris time) to present Hybribody Online Event Hybrigenics Services false MM/DD/YYYY

Meet us at MedVetPATHOGENS in Italy

Prato, Tuscany, Italy - 08-11 October

Barbara Ruggiero, Director of Business Development, will attend MedVetPATHOGENS in Prato, Italy, from October 08th to 11th, 2018.

This international meeting will bring together scientists and veterinarians to discuss bacterial pathogens and infection mechanisms in animals.

Meet Barbara to ask your question about Hybribody or to discover our VHH antibody synthetic library and how you can select and validate high quality nanobodies at a smart price, without animal immunization thanks to our optimized process.

 Contact us now to arrange a meeting with her during the meeting or later at your lab.

 

 MedVetPathogens

Add to Calendar 10-08-2018 00:00:00 10-11-2018 00:00:00 35 Meet us at MedVetPATHOGENS 2018 Meet Hybrigenics Services at MedVetPATHOGENS in Italy to learn more about Hybribody Prato, Tuscany, Italy microbiology society true MM/DD/YYYY

Nobel Prize in Chemistry 2018

Paris, France - 05 October

The 2018 Nobel Prize in Chemistry was awarded to 3 scientists. One half to Frances H. Arnold, California Institute of Technology (Caltech), Pasadena, USA, "for the directed evolution of enzymes" and the other half jointly to George P. Smith, University of Missouri, Columbia, USA, and Sir Gregory P. Winter, MRC Laboratory of Molecular Biology, Cambridge, UK, "for the phage display of peptides and antibodies."

The Phage display technique was first described in 1985 by George Smith and has been a formidable tool since. It consists of using the ability of bacteriophages to "display" proteins on their coat by inserting a gene encoding for a specific protein into the phage's genetic material. The specific protein will then be displayed outside the phage on its coat which allows to study protein–protein, protein–peptide, and protein–DNA interactions.

In 1991 the phage display technique was succesfully used for the first time to express antibodies at the phage surface. It is now widely used for in vitro antibody selection.

With this Nobel Prize we can see that this technique is still a powerful tool for the Biotechnology research.

At Hybrigenics, we use this technique coupled with our synthetic VHH library to select highly specific VHH antibodies in vitro, without animal immunization.

VHH antibody selection

Old news

Back to news

Back to Top